Redmile-Group

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
56
Total Value
1057997904
Accession Number
0001104659-25-049578
Form Type
13F-HR
Manager Name
Redmile-Group
Data Enrichment
100% identified
56 identified0 unidentified

Holdings

56 positions
Manager:
Search and click to pin securities to the top
Page 3 of 3
Oruka Therapeutics, Inc.
Shares:387.0K
Value:$4.0M
IGM Biosciences, Inc.
Shares:3.0M
Value:$3.4M
CYTOKINETICS INC
Shares:82.1K
Value:$3.3M
4D Molecular Therapeutics, Inc.
Shares:997.2K
Value:$3.2M
PLIANT THERAPEUTICS, INC.
Shares:2.1M
Value:$2.8M
LAVA Therapeutics NV
Shares:2.1M
Value:$2.6M
Atara Biotherapeutics, Inc.
Shares:441.7K
Value:$2.6M
Xeris Biopharma Holdings, Inc.
Shares:451.1K
Value:$2.5M
ALX ONCOLOGY HOLDINGS INC
Shares:3.6M
Value:$2.3M
Repare Therapeutics Inc.
Shares:1.9M
Value:$1.9M
Ventyx Biosciences, Inc.
Shares:1.6M
Value:$1.8M
Astria Therapeutics, Inc.
Shares:269.1K
Value:$1.4M
Invivyd, Inc.
Shares:2.3M
Value:$1.4M
Boundless Bio, Inc.
Shares:725.2K
Value:$1.1M
Kalaris Therapeutics, Inc.
Shares:83.0K
Value:$666.1K
Allakos Inc.
Shares:856.6K
Value:$195.0K